Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
6.41
-0.71 (-9.97%)
At close: Mar 6, 2026, 4:00 PM EST
6.52
+0.11 (1.72%)
After-hours: Mar 6, 2026, 7:49 PM EST
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $546.54 million as of March 6, 2026. Its market cap has increased by 171.65% in one year.
Market Cap
546.54M
Enterprise Value
487.83M
1-Year Change
171.65%
Ranking
Category
Stock Price
$6.41
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $546.54M, an increase of 57.42%. That is a compound annual growth rate of 9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 546.54M | 29.49% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 573.11M |
| Design Therapeutics | 572.49M |
| Larimar Therapeutics | 566.84M |
| MeiraGTx Holdings | 563.44M |
| Verastem | 560.39M |
| Fulcrum Therapeutics | 544.12M |
| Rigel Pharmaceuticals | 533.32M |
| Ocugen | 527.90M |